CERo Therapeutics News

CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rolfe Lindsey

Mar 27 21:30 ET

CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rapaport Robyn

Mar 27 21:30 ET

CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director LAPORTE KATHLEEN

Mar 27 21:30 ET

CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ehrlich Christopher B

Mar 27 21:30 ET

CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Corey Daniel

Mar 27 21:30 ET

CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Carter Charles Ross

Mar 27 21:30 ET

CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Byrnes Michael

Mar 27 21:30 ET

CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ATWOOD BRIAN G

Mar 27 21:25 ET

CERo Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer ATWOOD BRIAN G

Mar 11 19:28 ET

CERo Therapeutics | 3/A: Initial statement of beneficial ownership of securities (Amendment)-Officer Corey Daniel

Feb 26 21:42 ET

CERo Therapeutics | D: Filing D

Feb 23 17:20 ET

CERo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Shaolin Capital Management LLC(0.0%)

Feb 22 09:11 ET

CERo Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director LAPORTE KATHLEEN

Feb 21 18:02 ET

CERo Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer ATWOOD BRIAN G

Feb 21 18:01 ET

CERo Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jurgen van de Vyver(6.8%),Phoenix Biotech Sponsor, LLC(6.7%), etc.

Feb 20 17:22 ET

CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Loewy Caroline M

Feb 16 19:42 ET

CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kosacz Barbara

Feb 16 19:42 ET

CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Geffken Daniel E.

Feb 16 19:42 ET

CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Fisher Douglas Carl

Feb 16 19:42 ET

CERo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director LAPORTE KATHLEEN

Feb 16 19:42 ET